Results 111 to 120 of about 2,789 (159)

A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause. [PDF]

Menopause
Agrawal S, Agrawal S, LaPier Z, Nagpal S, Oot A, Friedman S, Hade EM, Nachtigall L, Brucker BM, Escobar C.   +9 more
europepmc   +1 more source

Treatment of Genitourinary Syndrome of Menopause in Breast Cancer and Gynecologic Cancer Survivors: Retrospective Analysis of Efficacy and Safety of Vaginal Estriol, Vaginal Dehydroepiandrosterone and Ospemifene. [PDF]

J Menopausal Med
Pennacchini E, Dall'Alba R, Iapaolo S, Marinelli M, Palazzetti PL, Zullo MA, Cervigni M, Morciano A, Campanella L, Ferraresi B, Schiavi MC.   +10 more
europepmc   +1 more source

Laser therapy for genitourinary syndrome of menopause: systematic review and meta-analysis of randomized controlled trial. [PDF]

Rev Bras Ginecol Obstet
Pessoa LLMN, de Souza ATB, Sarmento ACA, Ferreira Costa AP, Kelly Dos Santos I, Pereira de Azevedo E, de Medeiros KS, Gonçalves AK, Cobucci RN.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Genitourinary Syndrome of Menopause

Journal of Midwifery & Women's Health, 2021
AbstractGenitourinary syndrome of menopause (GSM) occurs in approximately 50% of menopausal women but is both underrecognized and undertreated despite numerous treatment options. Vaginal dryness, irritation, dyspareunia, urinary frequency, and urinary urgency are some of the more common symptoms that can have a negative effect on women's lives and ...
Queen Henry-Okafor, Erin DeBruyn, Melissa Ott, Ginny Moore   +3 more
openaire   +3 more sources

Genitourinary Syndrome of Menopause

Medical Clinics of North America, 2023
Introduced in 2014, genitourinary syndrome of menopause (GSM) describes a variety of unpleasant genital, sexual and urinary symptoms that can either be isolated or coexisting and are not related to other medical conditions. GSM is a chronic and progressive condition that requires early recognition and appropriate management to preserve urogenital ...
Shanice, Cox, Ryan, Nasseri, Rachel S, Rubin, Yahir, Santiago-Lastra   +3 more
openaire   +2 more sources

The genitourinary syndrome of menopause

Menopause, 2021
Abstract Genitourinary syndrome of menopause (GSM) refers to a collection of symptoms resulting from diminished hormonal, primarily estrogenic stimulation to the vulvovaginal or lower urinary tract and may affect up to 50% of postmenopausal women.
Nancy A, Phillips, Gloria A, Bachmann
openaire   +2 more sources

Genitourinary Syndrome of Menopause in Cancer Survivors

Clinical Obstetrics & Gynecology, 2023
Genitourinary syndrome of menopause (GSM) encompasses the symptoms of estrogen deprivation in the vaginal, vulva, and bladder areas. Because many cancer treatments induce a hypoestrogenic state, GSM is common in cancer survivors. The number of cancer survivors is increasing, and the unique aspects of GSM management for cancer survivors, such as the ...
Catherine L, Dugan, Alisha A, Othieno, Mindy E, Goldman   +2 more
openaire   +2 more sources